GR3024526T3 - Use of an emulsion containing omega-3 fatty acids to produce a medicament to be parenterally administered for treating inflammatory diseases. - Google Patents

Use of an emulsion containing omega-3 fatty acids to produce a medicament to be parenterally administered for treating inflammatory diseases.

Info

Publication number
GR3024526T3
GR3024526T3 GR970402169T GR970402169T GR3024526T3 GR 3024526 T3 GR3024526 T3 GR 3024526T3 GR 970402169 T GR970402169 T GR 970402169T GR 970402169 T GR970402169 T GR 970402169T GR 3024526 T3 GR3024526 T3 GR 3024526T3
Authority
GR
Greece
Prior art keywords
fatty acids
oils
omega
medicament
produce
Prior art date
Application number
GR970402169T
Other languages
English (en)
Inventor
Jeffrey Askanazi
David P Park Ave Katz
Ewald Fresenius Ag Schlotzer
Peter Fuerst
Original Assignee
Fresenius Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Ag filed Critical Fresenius Ag
Publication of GR3024526T3 publication Critical patent/GR3024526T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
GR970402169T 1992-04-28 1997-08-22 Use of an emulsion containing omega-3 fatty acids to produce a medicament to be parenterally administered for treating inflammatory diseases. GR3024526T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87524392A 1992-04-28 1992-04-28
PCT/EP1993/001011 WO1993021912A1 (de) 1992-04-28 1993-04-27 Verwendung einer omega-3-fettsäuren enthaltenden emulsion zur herstellung eines parenteral zu verabreichenden arzneimittels zur behandlung von entzündlichen erkrankungen

Publications (1)

Publication Number Publication Date
GR3024526T3 true GR3024526T3 (en) 1997-11-28

Family

ID=25365445

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970402169T GR3024526T3 (en) 1992-04-28 1997-08-22 Use of an emulsion containing omega-3 fatty acids to produce a medicament to be parenterally administered for treating inflammatory diseases.

Country Status (8)

Country Link
EP (1) EP0637957B1 (el)
JP (1) JP3559039B2 (el)
AT (1) ATE155684T1 (el)
DE (1) DE59306981D1 (el)
DK (1) DK0637957T3 (el)
ES (1) ES2107663T3 (el)
GR (1) GR3024526T3 (el)
WO (1) WO1993021912A1 (el)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780451A (en) * 1994-04-01 1998-07-14 Abbott Laboratories Nutritional product for a person having ulcerative colitis
US5952314A (en) 1994-04-01 1999-09-14 Demichele; Stephen Joseph Nutritional product for a person having ulcerative colitis
WO1995026646A1 (en) * 1994-04-01 1995-10-12 Abbott Laboratories Nutritional product for treatment of ulcerative colitis and use thereof
EP0689835A3 (en) * 1994-06-30 1996-04-17 Ajinomoto Kk Composition containing an amino acid mixture and at least one N-3 fatty acid
US6180671B1 (en) * 1998-03-10 2001-01-30 Beth Israel Deaconess Medical Center, Inc. Methods for treating disorders in which docosahexaenoic acid (DHA) levels are affected
US6140374A (en) * 1998-10-23 2000-10-31 Abbott Laboratories Propofol composition
US6191154B1 (en) * 1998-11-27 2001-02-20 Case Western Reserve University Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases
DK1296669T3 (da) * 2000-05-05 2006-04-18 Fresenius Kabi De Gmbh Kombinationspræparat af omega-3 fedtsyrer og konjugerede linoliesyrer til behandling af immunologisk prægede sygdomsbilleder
AU2002951913A0 (en) * 2002-10-08 2002-10-24 Chevis Agriservices & Consulting Pty. Limited Method of treatment
CN1166368C (zh) * 2003-02-26 2004-09-15 刘威 海狗油脂肪乳注射液、其制备方法及其在制备静脉注射剂中的应用
DE10361667A1 (de) * 2003-12-30 2005-07-28 Omega For Life Gmbh Neuartige Fettpulver
GB0403247D0 (en) 2004-02-13 2004-03-17 Tillotts Pharma Ag A pharmaceutical composition
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
EP1811935B1 (en) 2004-09-28 2016-03-30 Atrium Medical Corporation Heat cured gel and method of making
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
GB0425658D0 (en) 2004-11-22 2004-12-22 Stanford Rook Ltd Immunotherapeutic agent
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
WO2008119146A2 (en) * 2007-03-29 2008-10-09 Dair, Bicudo Piai Combi-preparation of phosphoethanolamine and omega-3-fatty acid for treating bronchial asthma and copd
BRPI0818079B8 (pt) 2007-10-09 2021-07-27 Enzymotec Ltd composição de lipídeo
US8241672B2 (en) * 2009-03-11 2012-08-14 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US9034389B2 (en) 2009-03-11 2015-05-19 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US8993625B2 (en) 2009-03-11 2015-03-31 Stable Solutions Llc Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
US20110200644A1 (en) * 2010-02-18 2011-08-18 Martek Biosciences Corporation DHA Ester Emulsions
WO2012009707A2 (en) 2010-07-16 2012-01-19 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
GB201216385D0 (en) 2012-09-13 2012-10-31 Chrysalis Pharma Ag A pharmaceutical composition
DE102015115877A1 (de) * 2015-09-21 2017-03-23 Eberhard Karls Universität Tübingen Medizinische Fakultät Prophylaxe und Behandlung von Mukoviszidose

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678808A (en) * 1985-10-15 1987-07-07 Baxter Travenol Laboratories, Inc. Rapid acting intravenous emulsions of omega-3 fatty acid esters
DE3734147C2 (de) * 1987-10-09 1998-10-29 Braun Melsungen Ag Isotone omega-3-fettsäurenhaltige Fettemulsion und ihre Verwendung

Also Published As

Publication number Publication date
ATE155684T1 (de) 1997-08-15
ES2107663T3 (es) 1997-12-01
JPH08500332A (ja) 1996-01-16
EP0637957A1 (de) 1995-02-15
DK0637957T3 (da) 1997-08-18
EP0637957B1 (de) 1997-07-23
JP3559039B2 (ja) 2004-08-25
WO1993021912A1 (de) 1993-11-11
DE59306981D1 (de) 1997-08-28

Similar Documents

Publication Publication Date Title
GR3024526T3 (en) Use of an emulsion containing omega-3 fatty acids to produce a medicament to be parenterally administered for treating inflammatory diseases.
GR3025216T3 (en) Use of an emulsion to prepare an intravenously administered medicament for treating skin diseases.
KR100657642B1 (ko) 에이코사펜타엔산 및/또는 스테아리돈산을 포함하여 이루어지는 오일
US5116624A (en) Efa compositions and therapy
US5198468A (en) Essential fatty acid composition
AU618814B2 (en) Essential fatty acid compositions
US5888541A (en) Fatty acid treatment
KR940003553A (ko) 지방산을 함유하는 조성물 및 지방산을 이용한 처지방법
CA2043137A1 (en) Essential fatty acid treatment
DE60000133T2 (de) Essentielle fettsäuren zur vorbeugung von kardiovaskulären anfällen
CA1310911C (en) Essential fatty acid compositions
DE69328618D1 (de) Medikamente auf der Basis von Docosahexaensäure, als Plättchenaggregationshemmer und gegen cerebralen Mangel an Fettsäuren, und Verfahren zur Herstellung.
EP1211305A4 (en) FAT COMPOSITIONS
US5516801A (en) Fatty acid treatment for ectopic calcium deposition
DK0456764T3 (da) Omega-3-fedtsyreholdig fedtemulsion til endotracheal indgift, fremstilling og anvendelse heraf
JPS60105471A (ja) 健康食品卵の生産方法
AU666748B2 (en) Fatty acid treatment
BE901206A (fr) Emulsion pour transfusion.
JP3093040B2 (ja) 敗血症用脂肪乳剤
FR2364652A1 (fr) Procede pour preparer une composition de traitement de l'intoxication alcoolique et composition obtenue